Fundamentals data is not available for this company.
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-12 | 811.71 | 31.55 | 26.42¢ | 14.6 | n/a | n/a | n/a | 0.0% |
| 31-Dec-13 | 866.67 | 45.51 | 38.90¢ | 9.9 | 0.2 | +47% | n/a | 0.0% |
Copyright © 2012 FactSet Research Systems Inc. All rights reserved.
No recent information was found.
| AstraZeneca, Merck team up on cancer treatment | 02-Jun-2009 | LA Times |
| Playboy sales slump produces sad story | 07-Aug-2008 | Chicago Tribune |
| Hospira stock sags despite swing to profit | 08-May-2008 | Chicago Tribune |
| Currency | US Dollars |
| Share Price | $ 3.75 |
| Change Today | $ -0.10 |
| % Change | -2.60 % |
| 52 Week High | $4.27 |
| 52 Week Low | $1.77 |
| Volume | 174,630 |
| Shares Issued | 104.10m |
| Market Cap | $390.39m |
| Beta | 1.84 |
| RiskGrade | 345 |
| Strong Buy | 1 |
| Buy | 0 |
| Neutral | 8 |
| Sell | 1 |
| Strong Sell | 0 |
| Total | 10 |

| Time | Volume / Share Price |
| 12:05 | 100 @ $3.75 |
| 12:05 | 100 @ $3.75 |
| 12:05 | 100 @ $3.75 |
| 12:05 | 100 @ $3.75 |
| 12:04 | 100 @ $3.75 |
You are here: research